Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D001437:Bacteriuria / Q000150:complications / Q000188:drug therapy; D001996:Bronchopneumonia / Q000150:complications / Q000188:drug therapy; D002512:Cephalothin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000150:complications*; D018805:Sepsis / Q000150:complications / Q000188:drug therapy; D014031:Tobramycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D002512:Cephalothin; D014031:Tobramycin